The gentle reader of this blog knows that on January 1, 2012 the new Federal Patent Court will take up work in Switzerland. As Switzerland's court of first instance in matters dealing with patents,…
Part 1 of the drama with the title "You Shall not Lie" is covered by a previous post.Part 2 has been briefly summarized two weeks ago by Miriam.
It appeared to me that the potential consequences of…
Vetrotech Saint-Gobain (International) (hereinafter referred to as “Vetrotech”) is the holder of European patent No. 0 620 781 designating France, filed on 5 August 1993 and granted on 19 May 1999,…
As the readers will know, the complex architecture of the European patent system allows third parties to challenge the validity of a patent by filing an opposition before the European Patent Office…
On 24 May 2011, the European Commission published the "Proposal for a Regulation concerning customs enforcement of intellectual property rights" (SEC(2011)597 final) to replace the present Regulation…
The Danish Supreme Court upheld the Maritime and Commercial Court's decision revoking an injunction against Teva issued by the Danish High Court. The Supreme Court ruled that a condition for the…
Contrary to the decision of the Opposition Division issued two weeks later, the District Court of The Hague held Novozymes’ patent to be novel and inventive. It also held the patent indirectly…
The Federal Institute of Intellectual Property can also issue a supplementary protection certificate to an applicant if a certificate for the same active pharmaceutical ingredients (API) or…
The difference between "inventiveness" within the meaning of the Austrian Patent Act and "inventive step" within the meaning of the Austrian Utility Model Act is too small to distinguish between…
by Miriam Büttner
This is a follow-up to the article of my colleague, Eike Schaper, of 17 August 2010 in which he refers to a ruling of the Düsseldorf Court of Appeal concerning the value in patent…
